Inari Medical, Inc. (NASDAQ: NARI) (Inari), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, has announced that it has entered into a definitive agreement to acquire LimFlow, S.A., a privately held pioneer in limb salvage for patients with chronic limb-threatening ischemia (CLTI). Under the terms of the agreement, Inari will pay US$250 million in cash at closing and LimFlow will be eligible to receive additional cash payments based on certain commercial and reimbursement milestones. The transaction is expected to close in the fourth quarter of 2023.

Latham & Watkins LLP advised Inari Medical in the transaction with a US corporate deal team led by Boston partner Julie Scallen and counsel Andrew Moosmann, with associates Taylor Ashton, Kennedy Holmes, and Amy Lutfi; a France corporate deal team led by Paris partner Pierre-Louis Cléro, with associates Christos Ierna and Juliette Gilioli. Advice was also provided on public company matters by Orange County partners Shayne Kennedy and Ross McAloon, with associates Eric Hanzich and AJ Blair; US IP and data privacy matters by Boston partners Charles Sanders and Sarah Gagan, with associates Debbie Hinck, Drew Roberts, and Zachary Shufro; on US FDA regulatory matters by Washington, D.C. partner Elizabeth Richards, with associate Kathryn Culver; on US healthcare regulatory matters by Bay Area partner Betty Pang, with associate Leia Gu; on EU healthcare regulatory matters by Paris/Brussels partner Eveline Van Keymeulen, with associates Jeanne Fabre and Alexandra Lauré; on EU antitrust matters by Brussels partner Héctor Armengod, with associates Markus Welzenbach and Victoria Marie-Christin Pfaff; on US antitrust matters by Washington, D.C. counsel Patrick English, with associate Kimon Kimball Triantafyllou; on US tax matters by Washington, D.C. partner Nicholas DeNovio, with associates Pierce Pandolph, and Emmanuel Kassim; on French tax matters by Paris partner Olivia Rauch-Ravisé, with associate Hugo Matricon; and on US benefits matters by Los Angeles partner Michelle L.C. Carpenter, with associate Sara Schlau.